X4 Pharmaceuticals, Inc — SC 13D/A Filings
7 SC 13D/A filings on record
This page lists all SC 13D/A filings submitted to the SEC by X4 Pharmaceuticals, Inc (XFOR), sorted by most recent first. Each row links to the full filing on EdgarLookup. X4 Pharmaceuticals, Inc has filed 7 SC 13D/A documents with the SEC since 2010. To view all SEC filings by X4 Pharmaceuticals, Inc, see the full filings list.
All
10-K
10-Q
144
3
4
4/A
424B1
424B3
424B5
425
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13D/A | GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1 | 0001072613-23-000346 | May 26, 2023 | — |
| SC 13D/A | GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1 | 0001072613-22-000662 | Dec 20, 2022 | — |
| SC 13D/A | SC 13D/A | 0001193125-19-195714 | Jul 17, 2019 | — |
| SC 13D/A | NEW ENTERPRISE ASSOCIATES 16, L.P. - X4 PHARMACEUTICALS, INC. 13D/A1 | 0001072613-19-000202 | May 28, 2019 | — |
| SC 13D/A | SC 13D/A | 0001193125-19-122305 | Apr 26, 2019 | — |
| SC 13D/A | AMENDMENT NO. 2 | 0000947871-19-000210 | Mar 19, 2019 | — |
| SC 13D/A | AMENDMENT NO. 1 | 0000947871-18-000061 | Jan 26, 2018 | — |